Mahadev Rao

10.6k total citations · 2 hit papers
160 papers, 7.8k citations indexed

About

Mahadev Rao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mahadev Rao has authored 160 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 30 papers in Oncology and 26 papers in Organic Chemistry. Recurrent topics in Mahadev Rao's work include Free Radicals and Antioxidants (14 papers), Cancer-related Molecular Pathways (12 papers) and Curcumin's Biomedical Applications (12 papers). Mahadev Rao is often cited by papers focused on Free Radicals and Antioxidants (14 papers), Cancer-related Molecular Pathways (12 papers) and Curcumin's Biomedical Applications (12 papers). Mahadev Rao collaborates with scholars based in India, United States and Canada. Mahadev Rao's co-authors include Sreejayan, Sreejayan Nair, D. Rajakumar, Richard G. Pestell, David S. Schrump, Chenguang Wang, Julie A. Hong, K. Indira Priyadarsini, Maofu Fu and Kongming Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Mahadev Rao

150 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxygen radical scavenging activity of curcumin

1990 952 citations Mahadev Rao et al. profile →
Nitric Oxide Scavenging by Curcuminoids

1997 914 citations Mahadev Rao et al. profile →

Peers

Countries citing papers authored by Mahadev Rao

Since Specialization

Citations

This map shows the geographic impact of Mahadev Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahadev Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahadev Rao more than expected).

Fields of papers citing papers by Mahadev Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahadev Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahadev Rao. The network helps show where Mahadev Rao may publish in the future.

Co-authorship network of co-authors of Mahadev Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Mahadev Rao. A scholar is included among the top collaborators of Mahadev Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahadev Rao. Mahadev Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Precise identification of viral–host integration events in HPV-positive cervical cancers by targeted long-read sequencing 2025 ·PubMed ·(unknown), (unknown), (unknown), Shirley Lewis, Krishna Sharan, Sandeep Mallya, (unknown), (unknown), Mahadev Rao, Daniel S. Higginson, Radhakrishnan Sabarinathan, Rama Rao Damerla	1
2	Influence of genetic polymorphisms on gefitinib pharmacokinetics and adverse drug reactions in non-small cell lung cancer patients 2025 ·Cancer and Metastasis Reviews ·(unknown), (unknown), Rama Rao Damerla, (unknown), (unknown), Murali Munisamy, Surulivelrajan Mallayasamy, Karthik Udupa, Jill Kolesar, Mahadev Rao	0
3	Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis 2024 ·European Journal of Drug Metabolism and Pharmacokinetics ·Levin Thomas, (unknown), Surulivelrajan Mallayasamy, Mahadev Rao	4
4	Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma 2024 ·Cancer Science ·(unknown), Rama Rao Damerla, (unknown), Sanjiban Chakrabarty, Mahadev Rao, Naveena A. N. Kumar	3
5	Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma 2024 ·Cells ·(unknown), (unknown), (unknown), Keerthana Krishnan, (unknown), Manash K. Paul, Neha Arya, Mahadev Rao, Vivek M. Rangnekar	0
6	Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour 2023 ·Journal of Maxillofacial and Oral Surgery ·Naveena A. N. Kumar, (unknown), (unknown), (unknown), (unknown), Adarsh Kudva, Mahadev Rao	6
7	The association between micronutrient levels and diabetic foot ulcer: A systematic review with meta-analysis 2023 ·Frontiers in Endocrinology ·(unknown), (unknown), Mazhuvancherry Kesavan Unnikrishnan, (unknown), Murali Munisamy, Kavitha Saravu, Gabriel Rodrigues, Mahadev Rao, Amit Kumar, Sonal Sekhar Miraj	9
8	Molecular Insights into the Mechanism of Modulatory Effects of Proton Pump Inhibitorson P-glycoprotein Mediated Drug Transport of Palbociclib and Ribociclib 2023 ·Current Drug Metabolism ·(unknown), (unknown), (unknown), Sumit Birangal, Gautham G. Shenoy, Mahadev Rao, Swapnil J. Dengale, Krishnamurthy Bhat, (unknown)	7
9	Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review 2022 ·Expert Review of Anti-infective Therapy ·(unknown), Mazhuvancherry Kesavan Unnikrishnan, (unknown), (unknown), Gabriel Rodrigues, Raghu Chandrashekar Hariharapura, (unknown), (unknown), (unknown), Chiranjay Mukhopadhyay, (unknown), Murali Munisamy, Mahadev Rao, (unknown), Sonal Sekhar Miraj	8
10	Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data 2021 ·Therapeutic Advances in Drug Safety ·Levin Thomas, Sumit Birangal, (unknown), Sonal Sekhar Miraj, Murali Munisamy, Muralidhar Varma, (unknown), Mithu Banerjee, Gautham G. Shenoy, Mahadev Rao	6
11	Effect of Vitamin D Supplementation in Type 2 Diabetes Patients with Tuberculosis: A Systematic Review 2021 ·Current Diabetes Reviews ·Sonal Sekhar Miraj, (unknown), (unknown), Muhammed Rashid, Levin Thomas, Gabriel Rodrigues, Mithu Banerjee, Bidita Khandelwal, Kavitha Saravu, Mahadev Rao	1
12	Vitamin D Supplementation in Diabetic Foot Ulcers: A Current Perspective 2020 ·Current Diabetes Reviews ·(unknown), Sonal Sekhar Miraj, (unknown), Murali Munisamy, Kavitha Saravu, Gabriel Rodrigues, Mahadev Rao	20
13	OPTICAL AND PHOTOLUMINESCENT STUDIES ON VO2+ DOPED SnO2 THIN FILMS 2017 ·RASAYAN Journal of Chemistry ·K. V. Lakshmi, (unknown), Mahadev Rao, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
14	STRUCTURAL AND OPTICAL CHARACTERIZATION OF ORGANIC LIGHT EMITTING DIODES 2017 ·RASAYAN Journal of Chemistry ·G. Sunita Sundari, Kundan Kumar, (unknown), Mahadev Rao, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
15	Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells 2015 ·Clinical Cancer Research ·Mahadev Rao, (unknown), Vivek Shukla, Young Ki Hong, Trevor Upham, R. Taylor Ripley, Julie A. Hong, Mary Zhang, (unknown), Patricia Fetsch, Markku Miettinen, Xinmin Li, Cody J. Peer, Tristan M. Sissung, William D. Figg, Assunta De Rienzo, Raphael Bueno, David S. Schrump	25
16	Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells 2012 ·Cancer Research ·Mary Zhang, Aarti Mathur, Yuwei Zhang, Sichuan Xi, Scott M. Atay, Julie A. Hong, (unknown), Trevor Upham, Clinton D. Kemp, R. Taylor Ripley, Gordon Wiegand, (unknown), Patricia Fetsch, Haresh Mani, Daniel Zlott, Robert W. Robey, Susan E. Bates, Xinmin Li, Mahadev Rao, David S. Schrump	82
17	Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy 2011 ·Clinical Cancer Research ·Clinton D. Kemp, Mahadev Rao, Sichuan Xi, Suzanne Inchauste, Haresh Mani, Patricia Fetsch, Armando Filie, Mary Zhang, Julie A. Hong, Robert L. Walker, Yuelin J. Zhu, R. Taylor Ripley, Aarti Mathur, Fang Liu, Maocheng Yang, Paul A. Meltzer, Víctor E. Márquez, Assunta De Rienzo, Raphael Bueno, David S. Schrump	77
18	Inhibition of Histone Lysine Methylation Enhances Cancer–Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer 2011 ·Cancer Research ·Mahadev Rao, Nachimuthu Chinnasamy, Julie A. Hong, Yuwei Zhang, Mary Zhang, Sichuan Xi, Fang Liu, Víctor E. Márquez, Richard A. Morgan, David S. Schrump	90
19	Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells 2009 ·Cancer Research ·Mustafa Hussain, Mahadev Rao, Ashley E. Humphries, Julie A. Hong, Fang Liu, Maocheng Yang, Diana Caragacianu, David S. Schrump	133
20	The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame ( *INK4a/ARF* ) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Distinct *cis* Elements 2004 ·Cancer Research ·Mark D’Amico, Kongming Wu, Maofu Fu, Mahadev Rao, Chris Albanese, Robert G. Russell, (unknown), David B. Bregman, Michael A. White, Richard G. Pestell	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact